Opus Genetics (IRD) Interest & Investment Income (2010 - 2020)
Opus Genetics (IRD) reported Interest & Investment Income of $1774.0 for Q3 2020, down 97.74% year-over-year from $78534.0 in Q4 2019, and down 70.64% quarter-over-quarter from $6042.0 in Q2 2020.
Opus Genetics (IRD) Interest & Investment Income (2010 - 2020) Analysis & Trends
Opus Genetics (IRD) has 11 years of Interest & Investment Income data on file, last reported at $1774.0 in Q3 2020.
- Interest & Investment Income for Q3 2020 came in at $1774.0, down 97.74% year-over-year; the trailing twelve-month figure through Sep 2020 was $99365.0 (down 68.21% YoY), and the FY2019 annual result was $313700.0, up 23.34% from the prior year.
- Interest & Investment Income declined to $1774.0 in Q3 2020 per IRD's latest filing, from $6042.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $96650.0 in Q2 2019 and troughed at $1774.0 in Q3 2020.
- A 5-year average of $49255.1 and a median of $55153.0 in 2018 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2018 and 2020: Interest & Investment Income surged 138.19% in 2018, then tumbled 97.74% in 2020.
- A 5-year view of Interest & Investment Income shows it stood at $34681.0 in 2016, then surged by 106.67% to $71674.0 in 2017, then slipped by 21.89% to $55982.0 in 2018, then grew by 2.05% to $57131.0 in 2019, then plunged by 96.89% to $1774.0 in 2020.
- Business Quant data shows IRD's Interest & Investment Income at $1774.0 in Q3 2020, $6042.0 in Q2 2020, and $34418.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1,774.00 |
| Jun 30, 2020 | 6,042.00 |
| Mar 31, 2020 | 34,418.00 |
| Dec 31, 2019 | 57,131.00 |
| Sep 30, 2019 | 78,534.00 |
| Jun 30, 2019 | 96,650.00 |
| Mar 31, 2019 | 81,385.00 |
| Dec 31, 2018 | 55,982.00 |
| Sep 30, 2018 | 55,153.00 |
| Jun 30, 2018 | 67,473.00 |
| Mar 31, 2018 | 75,736.00 |
| Dec 31, 2017 | 71,674.00 |
| Sep 30, 2017 | 60,750.00 |
| Jun 30, 2017 | 42,782.00 |
| Mar 31, 2017 | 31,797.00 |
| Dec 31, 2016 | 34,681.00 |
| Sep 30, 2016 | 26,145.00 |
| Jun 30, 2016 | 28,868.00 |
| Mar 31, 2016 | 28,871.00 |
| Dec 31, 2015 | 21,943.00 |